Abstract
Homologous recombination (HR) is often used to achieve targeted gene integration because of its higher precision and operability compared with microhomology-mediated end-joining (MMEJ) or non-homologous end-joining (NHEJ). It appears to be inefficient for gene integration in animal cells and embryos due to occurring only during cell division. Here we developed genome-wide high-throughput screening and a subsequently paired crRNA library screening to search for genes suppressing homology-directed repair (HDR). We found that, in the reporter system, HDR cells with knockdown of SHROOM1 were enriched as much as 4.7-fold than those with control. Down regulating SHROOM1 significantly promoted gene integration in human and mouse cells after cleavage by clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein-9 nuclease (Cas9), regardless of the donor types. The knock-in efficiency of mouse embryos could also be doubled by the application of SHROOM1 siRNA during micro-injection. The increased HDR efficiency of SHROOM1 deletion in HEK293T cells could be counteracted by YU238259, an HDR inhibitor, but not by an NHEJ inhibitor. These results indicated that SHROOM1 was an HDR-suppressed gene and that the SHROOM1 knockdown strategy may be useful for a variety of applications, including gene editing to generate cell lines and animal models for studying gene function and human diseases.
Highlights
Targeted gene integration is usually achieved by a method based on homologous recombination (HR) [1,2,3]
To identify the factors modulating homology-directed repair (HDR) efficiency at the double-strand break (DSB) site, we modified a previously described fluorescence-based system that measures I-SceI-induced HDR events to carry out a genome-wide screening [29]
U2OS, stably expressing the above system, we examined the levels of HDR modulation induced by individually transfecting the siRNAs of 21,257 genes by a high-content analysis instrument and calculation of fold change (FC) (Figure 1b)
Summary
Targeted gene integration is usually achieved by a method based on homologous recombination (HR) [1,2,3]. Other cell repair pathways like non-homologous end-joining (NHEJ) or microhomology-mediated end-joining (MMEJ) are used for targeted gene integration. The former seems to elevate the efficiency obviously, but it is unable to form a precise replacement and sometimes results in unforeseeable indels, making it difficult to generate endogenous and exogenous in-frame fusion genes for chimeric protein production [11,12]. The latter can manage accurate integration but has low efficiency [13,14]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.